Oxaliplatin and Raltitrexed Treatment of Colorectal Cancer With Liver Metastases
Status:
Unknown status
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was a randomized controlled trial to compare the effect of
oxaliplatin and raltitrexed treatment of colorectal cancer with liver metastases by TACE
hepatic artery infusion